USA
Cannabidiol-Based Medicine Descheduled In The USA – HempGazette
GW Pharmaceuticals announced yesterday the United States Drug Enforcement Administration (DEA) has determined Epidiolex is no longer subject to the Controlled Substances Act (CSA), effective immediately. Epidiolex is based on cannabidiol (CBD), a non-intoxicating cannabinoid extracted from either industrial hemp or medicinal cannabis. In June 2018, Epidiolex was approved by the U.S. Food and Drug …
Relevium launches organic hemp products in US – NutraIngredients-usa.com
Relevium sells a variety of dietary supplements on platforms such as amazon.com and walmart.com via a subsidiary called BioGanix. The company also has a subsidiary called BioCannabix focused on the medical cannabis markets in Canada and Europe. Relevium made the news in mid 2019 with the announcement of a plan to acquire a Colombian hemp …
Hemp Regulations Will Be Issued Within Weeks, Top USDA Official Says – Marijuana Moment
A leading advocacy group that’s dedicated to finding treatment options for Parkinson’s disease is backing three pieces of marijuana research legislation in Congress. The Michael J. Fox Foundation (MJFF)—named after the actor, who has Parkinson’s and established the nonprofit—said last week that lifting barriers to cannabis research, including rescheduling the plant under the Controlled Substances …